Macular edema. A complication of diabetic retinopathy

https://doi.org/10.1016/0039-6257(84)90227-3Get rights and content

Abstract

Diabetic macular edema is the leading cause of decreased vision from diabetic retinopathy. This decreased vision is caused by an increase in extracellular fluid within the retina distorting the retinal architecture and frequently taking on a pattern of cystoid macular edema. This fluid accumulates within the retina because of the breakdown of the barriers within the retinal blood vessels and possibly the pigment epithelium. Diabetic macular edema tends to be a chronic disorder. Although spontaneous recovery is not an uncommon occurrence, over one-half of diabetics with macular edema will lose two or more lines of visual acuity within two years. The most promising treatment for diabetic macular edema has been photocoagulation. It is recommended that in all patients with diabetic macular edema attempts be made to normalize elevated blood glucose, decrease elevated blood pressure, and improve cardiac or renal status. Reduction of serum lipids by diet or pharmacologic means is an unproven treatment at this time. The Early Treatment Diabetic Retinopathy Study hopefully will provide more definitive information as to whether photocoagulation is effective in various subgroups of patients with diabetic macular edema.

References (53)

  • FI Caird et al.

    Prognosis for vision in diabetic retinopathy

    Diabetes

    (1963)
  • FI Caird et al.
  • H Cheng et al.

    Diabetic maculopathy

    Trans Ophthalmol Soc UK

    (1972)
  • JG Cunha-Vaz

    Pathophysiology of diabetic retinopathy

    Br J Ophthalmol

    (1978)
  • DG Cogan et al.

    Retinal vascular patterns

    Arch Ophthalmol

    (1961)
  • JF Cullen et al.

    A controlled trial of atromid therapy in exudative diabetic retinopathy

    Trans Soc Ophthalmol UK

    (1964)
  • MD Davis

    The natural course of diabetic retinopathy

    Trans Am Acad Ophthalmol Otolaryngol

    (1967)
  • MD Davis

    The natural history of diabetic retinopathy

    Sight Sav Rev

    (1969)
  • JH Dobree

    Recent advances in the treatment of diabetic retinopathy

    Br J Ophthalmol

    (1974)
  • JH Dobree

    Simple diabetic retinopathy

    Br J Ophthalmol

    (1970)
  • JH Dobree et al.

    Treatment of proliferative diabetic retinopathy by repeated light coagulation

    Br J Ophthalmol

    (1973)
  • L Duncan

    A three-year trial of atromid therapy in exudative diabetic retinopathy

    Diabetes

    (1968)
  • The Early Treatment Diabetic Retinopathy Study Manual of Operations. ETDRS Coordinating Center, Department of...
  • M Harold et al.

    A double-blind controlled trial of clofibrate in the treatment of diabetic retinopathy

    Diabetes

    (1969)
  • P Henkind et al.

    Retinal edema: Postulated mechanism(s)

  • D Job et al.

    Effect of multiple daily insulin injections on the course of diabetic retinopathy

    Diabetes

    (1976)
  • Cited by (290)

    • Algal metabolites: Paving the way towards new generation antidiabetic therapeutics

      2023, Algal Research
      Citation Excerpt :

      Further, biguanides inhibit liver gluconeogenesis which results in the treatment of hyperglycemia [44]. Diabetes is a complex disorder in which disturbance in glucose levels leads to many complications [45–65]. The fasting glucose has its origin from de novo synthesis of glucose (gluconeogenesis), in addition to the breakdown of stored glycogen (glycogenolysis) from the liver [66].

    • Recent trends in drug-delivery systems for the treatment of diabetic retinopathy and associated fibrosis

      2021, Advanced Drug Delivery Reviews
      Citation Excerpt :

      CTGF up-regulation by advanced glycation end-products (AGEs) and growth factors has also been proposed to have a role in the earlier stages of the disease as evidence regarding its contribution to the thickening of capillary basement membranes and loss of pericytes have been reported [26]. Diabetic macular oedema (DMO) can surface at any stage of DR progression and is due to the increase of vascular permeability, resultant from the breakdown of the BRB, and accumulation of extracellular fluid in the macula [8,27]. Despite extensive research, the underlying pathogenic mechanisms leading to DR are still unclear.

    • The Fovea: Structure, Function, Development, and Tractional Disorders

      2021, The Fovea: Structure, Function, Development, and Tractional Disorders
    View all citing articles on Scopus
    View full text